Literature DB >> 8522668

Thrombomodulin in intensive care patients.

J Boldt1, T Wollbrück, S Sonneborn, A Welters, G Hempelmann.   

Abstract

OBJECTIVE: Changes of endothelial-related coagulation was studied in intensive care patients.
DESIGN: Descriptive, prospective.
SETTING: Clinical investigation, intensive care unit of an university hospital. PATIENTS: 40 consecutive critically ill patients with severe trauma (n = 20) or postoperative complications (n = 20) were studied. 14 patients suffered from sepsis, 12 patients suffered from acute renal failure.
INTERVENTIONS: 12 patients with acute renal failure were continuously hemofiltrated. All patients were on continuous sedation (fentanyl and midazolam) and mechanical ventilation. MEASUREMENTS: In addition to standard coagulation variables, thrombomodulin (TM), protein C and protein S as well as thrombin/antithrombin III (TAT) plasma concentrations were measured from arterial blood samples using enzyme-linked immuno-sorbent assays (ELISA). Measurements were carried out on the day of admission (trauma patients) or on the day of diagnosis of sepsis and during the next 4 days. MAIN
RESULTS: Throughout the entire investigation period, TM plasma concentrations in patients with sepsis (baseline: 90 +/- 25 micrograms/l, 4th day: 152 +/- 28 micrograms/l) were significantly higher than in non-septic patients (baseline: 60 +/- 29 micrograms/l, 4th day: 42 +/- 15 micrograms/l). 15 of the 40 patients died within or after the end of the investigation period. TM plasma concentrations of survivors were lower (maximum: 63 +/- 18 micrograms/l) than in the non-survivors (maximum: 159 +/- 22 micrograms/l) (p < 0.05). Hemofiltered patients showed higher TM plasma levels, which further increased during the hemofiltration procedure. Protein C and (free) protein S were without significant group differences. TAT plasma levels were elevated above normal in all patients (no group differences).
CONCLUSIONS: Besides plasmatic and platelet-related coagulation, endothelium-associated coagulation appears to be also important for maintenance of hemostasis. TM plasma concentrations were elevated in all our critically ill patients, particularly when sepsis was evident. This appears to be most likely due to endothelial membrane damage with increased release of membrane-bound TM into the circulating blood in these patients. The importance of the elevated plasma levels of circulating soluble TM on hemostasis in these patients is an ongoing debate and warrants further studies.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8522668     DOI: 10.1007/bf01711542

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  27 in total

Review 1.  Endothelial cells in hemostasis, thrombosis, and inflammation.

Authors:  K K Wu
Journal:  Hosp Pract (Off Ed)       Date:  1992-04-15

2.  The role of protein C as an inhibitor of blood clotting during extracorporeal circulation.

Authors:  P Feindt; I Volkmer; U T Seyfert; H Haack
Journal:  Thorac Cardiovasc Surg       Date:  1991-12       Impact factor: 1.827

3.  Plasma thrombomodulin in health and diseases.

Authors:  S Takano; S Kimura; S Ohdama; N Aoki
Journal:  Blood       Date:  1990-11-15       Impact factor: 22.113

Review 4.  The role of thrombomodulin in the regulation of hemostatic interactions.

Authors:  E A Thompson; H H Salem
Journal:  Prog Hematol       Date:  1987

5.  Thrombomodulin Biology and potential cardiovascular applications.

Authors:  W A Dittman
Journal:  Trends Cardiovasc Med       Date:  1991-12       Impact factor: 6.677

6.  Tumor necrosis factor leads to the internalization and degradation of thrombomodulin from the surface of bovine aortic endothelial cells in culture.

Authors:  K L Moore; C T Esmon; N L Esmon
Journal:  Blood       Date:  1989-01       Impact factor: 22.113

7.  Hypoxia modulates the barrier and coagulant function of cultured bovine endothelium. Increased monolayer permeability and induction of procoagulant properties.

Authors:  S Ogawa; H Gerlach; C Esposito; A Pasagian-Macaulay; J Brett; D Stern
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

8.  Fluctuations in plasma levels of thrombomodulin in patients with DIC.

Authors:  K Amano; M Tateyama; H Inaba; K Fukutake; M Fujimaki
Journal:  Thromb Haemost       Date:  1992-10-05       Impact factor: 5.249

9.  Soluble thrombomodulin antigen in conditioned medium is increased by damage of endothelial cells.

Authors:  H Ishii; H Uchiyama; M Kazama
Journal:  Thromb Haemost       Date:  1991-05-06       Impact factor: 5.249

10.  Changes in plasma levels of thrombomodulin during haemodialysis.

Authors:  M Yamazaki; H Asakura; T Sato; Y Tsugawa; M Matsumura; Y Kawamura; T Ohka; T Matsuda
Journal:  Blood Coagul Fibrinolysis       Date:  1992-02       Impact factor: 1.276

View more
  3 in total

1.  Pro-Coagulant Endothelial Dysfunction Results from EHEC Shiga Toxins and Host Damage-Associated Molecular Patterns.

Authors:  Chad L Mayer; Caitlin S L Parello; Benjamin C Lee; Kiyoshi Itagaki; Shinichiro Kurosawa; Deborah J Stearns-Kurosawa
Journal:  Front Immunol       Date:  2015-04-07       Impact factor: 7.561

2.  Markers of acute kidney injury in patients with sepsis: the role of soluble thrombomodulin.

Authors:  Shinshu Katayama; Shin Nunomiya; Kansuke Koyama; Masahiko Wada; Toshitaka Koinuma; Yuya Goto; Ken Tonai; Jun Shima
Journal:  Crit Care       Date:  2017-08-25       Impact factor: 9.097

3.  Using Complementary and Alternative Medicines to Target the Host Response during Severe Influenza.

Authors:  Lisa M Alleva; Charles Cai; Ian A Clark
Journal:  Evid Based Complement Alternat Med       Date:  2009-09-24       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.